FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098658 [Registered on: 08/12/2025] Trial Registered Prospectively
Last Modified On: 08/12/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   Testing Computer Programs that Automatically Identify Body Organs in Cancer Patients Scans to Improve Radiation Therapy Planning 
Scientific Title of Study   Deep Learning For Radiotherapy Autosegmentation Workflow : Prospective Multicenter Evaluation Study Protocol 
Trial Acronym  DRAW ME 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Santam Chakraborty 
Designation  Senior Consultant 
Affiliation  Tata Medical Center 
Address  Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal

North Twentyfour Parganas
WEST BENGAL
700160
India 
Phone  03366057402  
Fax    
Email  drsantam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Santam Chakraborty 
Designation  Senior Consultant 
Affiliation  Tata Medical Center 
Address  Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal


WEST BENGAL
700160
India 
Phone  03366057402  
Fax    
Email  drsantam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Santam Chakraborty 
Designation  Senior Consultant 
Affiliation  Tata Medical Center 
Address  Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal


WEST BENGAL
700160
India 
Phone  03366057402  
Fax    
Email  drsantam@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Tata Medical Center 
Address  Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal 700160 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Santam Chakraborty  Tata Medical Center  Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal
North Twentyfour Parganas
WEST BENGAL 
03366057402

santam.chakraborty@tmckolkata.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tata Medical Center IRB  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D499||Neoplasm of unspecified behavior of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  The target population is patients with cancer being treated with radiotherapy for whom automatic segmentation models are available in the DRAW system. Currently this includes:
1. CNS malignancies
2. Breast cancers
3. Head Neck cancers
4. Lung cancers
5. Esophageal cancers
6. Prostate cancers
7. Gynecological cancers
8. Rectal cancers 
 
ExclusionCriteria 
Details  Model not available for the cancer site for automatic segmentation 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Qualitative Validation: Number of cases where no or minor modifications were required.  24 months 
 
Secondary Outcome  
Outcome  TimePoints 
Quantitative Validation: Average volumetric dice similarity between the autosegmented contours and the manually segmented structure sets. This will be compared against the reference VDS value.  24 months 
Time taken for modification: The estimated time required for making the modifications required for the cases after automatic segmentation will be reported.   24 months 
 
Target Sample Size   Total Sample Size="1000"
Sample Size from India="1000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Automatic segmentation is gaining increasing acceptance in Radiation Oncology to reduce burden and improve consistency. However commercial systems are expensive and inflexible. Open source systems are flexible but require a significant technological know-how for implementation. The team from Tata Medical Center Kolkata and IIT Kharagpur have developed a deep-learning based autosegmentation system which can be deployed with minimal capital expenditure and uses a distributed client-server architecture to allow fast parallel processing of cases. At the time of this version, the DRAW system uses nnU-Net for the deep-learning-based modelling.

Aims
To evaluate the real world use of the  DRAW system in a real world setting

Objectives
To determine if the DRAW system can be successfully installed and configured at multiple hospitals (Implementation objective)
To determine if the system performance is considered acceptable for the users at the hospitals where the DRAW system was installed (Validation objective)

Endpoints
To determine the percentage of centers where the DRAW system was successfully installed and configured. The DRAW client system should be installed and work with the DICOM data storage system available at the participating center to be considered as a successful install. 
Qualitative: At least 50% of the cases were segmented with no or minor modifications/errors as determined qualitatively by the end users.
Quantitative: At least 70% of the segmented structures have an average volumetric dice similarity score (VDS) not less than 0.10 points below the reference VDS. The reference value will be defined based on the VDS reported in the literature (or if not available in the literature then the model validation statistics obtained from the DRAW segmentation pipeline). 

Design
Multicenter, single-arm, prospective cohort study

Methods
The DRAW system will be installed in the participating hospitals and configured to integrate it with the planning workflow. Autosegmentation will be performed by the DRAW system and this will be reviewed by the oncologists at the participating center. Qualitative evaluation of the contours will be performed by the oncologists. De-identified DICOM data will be used to determine the spatial similarity between autosegmented and manually segmented structures for quantitative evaluation.

Statistical Analysis
Descriptive summary statistics will be presented for each endpoint along with appropriate visualization. For proportions we will also report the corresponding binomial 95% confidence intervals. For quantitative data, the median, mean and 95% confidence intervals of the mean shall be reported.  

Sample size
The minimum sample size for the study is 1000 patients based on the quantitative validation objective. 

Study Duration
2 years






 
Close